Heartbeam Net Worth
Heartbeam Net Worth Breakdown | BEAT |
Heartbeam Net Worth Analysis
Heartbeam's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Heartbeam's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Heartbeam's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Heartbeam's net worth analysis. One common approach is to calculate Heartbeam's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Heartbeam's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Heartbeam's net worth. This approach calculates the present value of Heartbeam's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Heartbeam's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Heartbeam's net worth. This involves comparing Heartbeam's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Heartbeam's net worth relative to its peers.
Enterprise Value |
|
To determine if Heartbeam is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Heartbeam's net worth research are outlined below:
| Heartbeam appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (14.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heartbeam currently holds about 9.27 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16. | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Personal Care Stocks Q3 In Review BeautyHealth Vs Peers |
Heartbeam Quarterly Good Will |
|
Heartbeam uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Heartbeam. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Heartbeam's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Heartbeam Target Price Consensus
Heartbeam target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Heartbeam's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Buy |
Most Heartbeam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Heartbeam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Heartbeam, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationHeartbeam Target Price Projection
Heartbeam's current and average target prices are 3.06 and 5.39, respectively. The current price of Heartbeam is the price at which Heartbeam is currently trading. On the other hand, Heartbeam's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Heartbeam Target Price
Know Heartbeam's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Heartbeam is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Heartbeam backward and forwards among themselves. Heartbeam's institutional investor refers to the entity that pools money to purchase Heartbeam's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Pasadena Private Wealth, Llc | 2024-09-30 | 60.6 K | Blackrock Inc | 2024-06-30 | 51.4 K | Advisory Research Inc | 2024-09-30 | 50 K | Northern Trust Corp | 2024-09-30 | 46.8 K | D'orazio & Associates Inc | 2024-09-30 | 33 K | Xtx Topco Ltd | 2024-09-30 | 14.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 14.5 K | Harbour Investments, Inc. | 2024-09-30 | 14.2 K | Advisor Group Holdings, Inc. | 2024-06-30 | 11.6 K | Vanguard Group Inc | 2024-09-30 | 750.7 K | Smith, Salley & Associates, Llc | 2024-09-30 | 250 K |
Follow Heartbeam's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.6 M.Market Cap |
|
Project Heartbeam's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.85) | (0.90) | |
| Return On Capital Employed | (0.96) | (0.91) | |
| Return On Assets | (0.85) | (0.90) | |
| Return On Equity | (0.92) | (0.87) |
When accessing Heartbeam's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Heartbeam's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Heartbeam's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Heartbeam's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heartbeam. Check Heartbeam's Beneish M Score to see the likelihood of Heartbeam's management manipulating its earnings.
Evaluate Heartbeam's management efficiency
Heartbeam has return on total asset (ROA) of (0.6975) % which means that it has lost $0.6975 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1362) %, meaning that it created substantial loss on money invested by shareholders. Heartbeam's management efficiency ratios could be used to measure how well Heartbeam manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.9 in 2024. Return On Capital Employed is likely to gain to -0.91 in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 16.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.78 | 0.74 | |
| Tangible Book Value Per Share | 0.78 | 0.82 | |
| Enterprise Value Over EBITDA | 46.81 | 49.15 | |
| Price Book Value Ratio | 3.00 | 3.15 | |
| Enterprise Value Multiple | 46.81 | 49.15 | |
| Price Fair Value | 3.00 | 3.15 | |
| Enterprise Value | 32.6 M | 45.9 M |
Evaluating the management effectiveness of Heartbeam allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Heartbeam Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Return On Equity (1.14) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heartbeam insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heartbeam's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heartbeam insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Heartbeam Corporate Filings
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 23rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 20th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 11th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Heartbeam Earnings Estimation Breakdown
The calculation of Heartbeam's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Heartbeam is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Heartbeam is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Heartbeam Earnings Projection Consensus
Suppose the current estimates of Heartbeam's value are higher than the current market price of the Heartbeam stock. In this case, investors may conclude that Heartbeam is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Heartbeam's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 2 | 81.13% | -0.19 | 0.0 | -0.68 |
Heartbeam Earnings History
Earnings estimate consensus by Heartbeam analysts from Wall Street is used by the market to judge Heartbeam's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Heartbeam's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Heartbeam Quarterly Gross Profit |
|
Heartbeam Earnings per Share Projection vs Actual
Actual Earning per Share of Heartbeam refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Heartbeam predict the company's earnings will be in the future. The higher the earnings per share of Heartbeam, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Heartbeam Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Heartbeam, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Heartbeam should always be considered in relation to other companies to make a more educated investment decision.Heartbeam Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Heartbeam's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.17 | -0.19 | -0.02 | 11 | ||
2024-08-08 | 2024-06-30 | -0.16 | -0.19 | -0.03 | 18 | ||
2024-05-09 | 2024-03-31 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-03-20 | 2023-12-31 | -0.13 | -0.15 | -0.02 | 15 | ||
2023-11-14 | 2023-09-30 | -0.13 | -0.13 | 0.0 | 0 | ||
2023-08-10 | 2023-06-30 | -0.23 | -0.16 | 0.07 | 30 | ||
2023-05-11 | 2023-03-31 | -0.31 | -0.5 | -0.19 | 61 | ||
2023-03-16 | 2022-12-31 | -0.37 | -0.45 | -0.08 | 21 | ||
2022-11-10 | 2022-09-30 | -0.32 | -0.44 | -0.12 | 37 | ||
2022-08-11 | 2022-06-30 | -0.27 | -0.43 | -0.16 | 59 | ||
2022-05-12 | 2022-03-31 | -0.19 | -0.27 | -0.08 | 42 | ||
2022-03-24 | 2021-12-31 | -0.11 | -0.24 | -0.13 | 118 | ||
2021-07-09 | 2021-06-30 | 0 | -0.02 | -0.02 | 0 | ||
2021-06-30 | 2021-03-31 | 0 | -0.2554 | -0.2554 | 0 | ||
2021-03-31 | 2020-12-31 | 0 | -0.057 | -0.057 | 0 | ||
2020-10-29 | 2020-09-30 | 0.38 | 0.45 | 0.07 | 18 | ||
2020-07-30 | 2020-06-30 | 0.16 | 0.35 | 0.19 | 118 | ||
2020-05-06 | 2020-03-31 | 0.43 | 0.45 | 0.02 | 4 | ||
2020-02-26 | 2019-12-31 | 0.48 | 0.48 | 0.0 | 0 | ||
2019-11-05 | 2019-09-30 | 0.5 | 0.52 | 0.02 | 4 | ||
2019-07-30 | 2019-06-30 | 0.45 | 0.53 | 0.08 | 17 | ||
2019-04-25 | 2019-03-31 | 0.41 | 0.42 | 0.01 | 2 | ||
2019-02-21 | 2018-12-31 | 0.43 | 0.56 | 0.13 | 30 | ||
2018-10-30 | 2018-09-30 | 0.32 | 0.53 | 0.21 | 65 | ||
2018-07-25 | 2018-06-30 | 0.31 | 0.46 | 0.15 | 48 | ||
2018-04-25 | 2018-03-31 | 0.23 | 0.39 | 0.16 | 69 | ||
2018-02-22 | 2017-12-31 | 0.24 | 0.32 | 0.08 | 33 | ||
2017-11-07 | 2017-09-30 | 0.25 | 0.16 | -0.09 | 36 | ||
2017-08-08 | 2017-06-30 | 0.21 | 0.23 | 0.02 | 9 | ||
2017-05-03 | 2017-03-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2017-02-22 | 2016-12-31 | 0.18 | 0.23 | 0.05 | 27 | ||
2016-11-02 | 2016-09-30 | 0.18 | 0.21 | 0.03 | 16 | ||
2016-08-02 | 2016-06-30 | 0.17 | 0.2 | 0.03 | 17 | ||
2016-04-26 | 2016-03-31 | 0.1 | 0.2 | 0.1 | 100 | ||
2016-02-17 | 2015-12-31 | 0.11 | 0.15 | 0.04 | 36 | ||
2015-11-09 | 2015-09-30 | 0.1 | 0.13 | 0.03 | 30 | ||
2015-08-06 | 2015-06-30 | 0.09 | 0.12 | 0.03 | 33 | ||
2015-05-06 | 2015-03-31 | 0.02 | 0.06 | 0.04 | 200 | ||
2015-02-19 | 2014-12-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2014-10-30 | 2014-09-30 | 0.02 | 0.06 | 0.04 | 200 | ||
2014-08-01 | 2014-06-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2014-05-06 | 2014-03-31 | 0 | -0.04 | -0.04 | 0 | ||
null | null | null | null | null | 0 | ||
2013-11-05 | 2013-09-30 | -0.02 | -0.12 | -0.1 | 500 | ||
2012-11-05 | 2012-09-30 | -0.09 | -0.12 | -0.03 | 33 | ||
2012-08-08 | 2012-06-30 | -0.04 | -0.01 | 0.03 | 75 | ||
2012-05-08 | 2012-03-31 | -0.11 | -0.1 | 0.01 | 9 | ||
2012-02-22 | 2011-12-31 | -0.16 | -0.04 | 0.12 | 75 | ||
2011-11-08 | 2011-09-30 | -0.08 | -0.21 | -0.13 | 162 | ||
2011-08-08 | 2011-06-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2011-05-03 | 2011-03-31 | -0.15 | -0.02 | 0.13 | 86 | ||
2011-02-17 | 2010-12-31 | -0.16 | -0.13 | 0.03 | 18 | ||
2010-11-08 | 2010-09-30 | -0.05 | -0.25 | -0.2 | 400 | ||
2010-07-28 | 2010-06-30 | -0.1 | -0.02 | 0.08 | 80 | ||
2010-04-28 | 2010-03-31 | -0.18 | -0.13 | 0.05 | 27 | ||
2010-02-17 | 2009-12-31 | -0.14 | -0.24 | -0.1 | 71 | ||
2009-11-06 | 2009-09-30 | 0.03 | -0.1 | -0.13 | 433 | ||
2009-08-05 | 2009-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2009-04-30 | 2009-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2009-02-17 | 2008-12-31 | 0.15 | 0.16 | 0.01 | 6 | ||
2008-10-30 | 2008-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2008-07-22 | 2008-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2008-04-29 | 2008-03-31 | 0.02 | 0.02 | 0.0 | 0 |
Heartbeam Corporate Management
| Branislav Vajdic | President, Founder | Profile | |
| FACC MD | Chief Officer | Profile | |
| Timothy Cruickshank | Chief Officer | Profile | |
| Richard Brounstein | CFO Treasurer | Profile | |
| Richa Gujarati | Senior Product | Profile | |
| Kenneth Persen | Chief Officer | Profile |
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.